China NMPA Product Recall - Implantable intravenous drug delivery system
China NMPA product recall for Implantable intravenous drug delivery system by Smiths Medical ASD, Inc. published July 15, 2019. Recall level: Level 3. Smiths Medical ASD, Inc., through its local agent Smiths Medical Devices (Beijing) Co., Ltd., initia
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Implantable intravenous drug delivery system by Smiths Medical ASD, Inc. published July 15, 2019. Recall level: Level 3. Smiths Medical ASD, Inc., through its local agent Smiths Medical Devices (Beijing) Co., Ltd., initia
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Smiths Medical ASD, Inc.Inspection Date
Unknown Date
Product Type
ID: f6688251-8fa6-40d3-a3c8-b9997fc03897
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox